<DOC>
	<DOC>NCT01047046</DOC>
	<brief_summary>This study is a retrospective chart review including all patients who received surgical placement of a SNM device with Dr. Noblett from 2001 to the present.</brief_summary>
	<brief_title>Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder</brief_title>
	<detailed_description>The following data will be collected from patient charts: age at time of surgery, gravidity/parity, body mass index, pre-existing medical conditions/surgical history, current medications, menopausal status, form and severity of OAB symptoms, other previously or currently used interventions, method of SNM device placement, observed motor/sensory response, percent improvement of symptoms, follow-up OAB symptoms, frequency of InterStim settings adjustments, adverse events, significant changes in health, and incidence/reason for drop out.</detailed_description>
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Cholinergic Antagonists</mesh_term>
	<criteria>Female patients with symptoms of OAB, namely urge incontinence and urgencyfrequency. Ages 18 and older. Any patient who received surgical placement of an SNM device to treat nonobstructive urinary retention, or the symptoms of an underlying neurologic pathology, such as Parkinson's or Multiple Sclerosis.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>SNM device</keyword>
	<keyword>Chart review of patients with surgical placed SNM device</keyword>
</DOC>